|
EXOC8 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.078800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.110370E-01 |
| Normal-vs-Stage2 |
8.954400E-01 |
| Normal-vs-Stage3 |
2.218400E-02 |
| Normal-vs-Stage4 |
9.86290000000167E-05 |
| Stage1-vs-Stage2 |
2.687800E-01 |
| Stage1-vs-Stage3 |
2.840600E-04 |
| Stage1-vs-Stage4 |
2.07850000544241E-08 |
| Stage2-vs-Stage3 |
2.142800E-01 |
| Stage2-vs-Stage4 |
2.802300E-02 |
| Stage3-vs-Stage4 |
1.332550E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.735800E-01 |
| Normal-vs-AfricanAmerican |
2.412000E-01 |
| Normal-vs-Asian |
9.501000E-01 |
| Caucasian-vs-AfricanAmerican |
4.275800E-01 |
| Caucasian-vs-Asian |
8.456600E-01 |
| AfricanAmerican-vs-Asian |
5.885000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.545700E-02 |
| Normal-vs-Female |
2.124200E-01 |
| Male-vs-Female |
1.884250E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.452830E-01 |
| Normal-vs-Age(41-60Yrs) |
6.413000E-01 |
| Normal-vs-Age(61-80Yrs) |
5.708000E-01 |
| Normal-vs-Age(81-100Yrs) |
9.404400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.133800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.223400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.150600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.361000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.836000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.420800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.689500E-02 |
| Normal-vs-Grade 2 |
1.079170E-01 |
| Normal-vs-Grade 3 |
7.283800E-02 |
| Normal-vs-Grade 4 |
3.61609999999235E-06 |
| Grade 1-vs-Grade 2 |
1.337960E-01 |
| Grade 1-vs-Grade 3 |
2.604400E-03 |
| Grade 1-vs-Grade 4 |
2.24449999997045E-06 |
| Grade 2-vs-Grade 3 |
6.615300E-04 |
| Grade 2-vs-Grade 4 |
4.94609997403472E-09 |
| Grade 3-vs-Grade 4 |
3.539400E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.849900E-04 |
| Normal-vs-ccB subtype |
2.002000E-03 |
| ccA subtype-vs-ccB subtype |
8.30490121117577E-11 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.928200E-01 |
| Normal-vs-N1 |
1.254770E-01 |
| N0-vs-N1 |
2.110200E-01 |
|
|
